APO Research
Talk to an analyst

APO RESEARCH · REPORT

Dry Eye Therapy Eye Drops

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Dry Eye Therapy Eye Drops Market Outlook and Growth Opportunities 2026

27 December 2025198 pages

Choose your research edition.

Industry ResearchDry Eye Therapy Eye Drops Industry Research Report 2026124 pages · $2,950 USDIndustry Growth & TrendsGlobal Dry Eye Therapy Eye Drops Industry Growth and Trends Forecast to 2032108 pages · $3,450 USDMarket StructureGlobal Dry Eye Therapy Eye Drops Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Dry Eye Therapy Eye Drops Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal Dry Eye Therapy Eye Drops Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

The global Dry Eye Therapy Eye Drops market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Dry Eye Therapy Eye Drops is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Dry Eye Therapy Eye Drops is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Dry Eye Therapy Eye Drops is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Dry Eye Therapy Eye Drops market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Dry Eye Therapy Eye Drops market include Novartis, Rohto, CooperVision, Santen Pharma, Alcon, AbbVie, Zhenshiming, URSAPHARM and Thea pharmaceuticals, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Dry Eye Therapy Eye Drops market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Dry Eye Therapy Eye Drops and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Dry Eye Therapy Eye Drops sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Dry Eye Therapy Eye Drops market size, projected growth trends, production technologies, key applications, and end-use industries.

Dry Eye Therapy Eye Drops Segment by Company

Novartis

Rohto

CooperVision

Santen Pharma

Alcon

AbbVie

Zhenshiming

URSAPHARM

Thea pharmaceuticals

Prestige Consumer Healthcare

OmniVision Pharma

LION

Kenvue (VISINE)

Bausch Health

Dry Eye Therapy Eye Drops Segment by Type

Sodium Hyaluronate Eye Drops

Sodium Carboxymethylcellulose Eye Drops

Other

Dry Eye Therapy Eye Drops Segment by Application

Middle Age

Teenagers

Older Adult

Dry Eye Therapy Eye Drops Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Dry Eye Therapy Eye Drops status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Dry Eye Therapy Eye Drops market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Dry Eye Therapy Eye Drops significant trends, drivers, influence factors in global and regions.

6. To analyze Dry Eye Therapy Eye Drops competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Dry Eye Therapy Eye Drops market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Dry Eye Therapy Eye Drops and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Dry Eye Therapy Eye Drops.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Dry Eye Therapy Eye Drops market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Dry Eye Therapy Eye Drops industry.

Chapter 3: Detailed analysis of Dry Eye Therapy Eye Drops manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Dry Eye Therapy Eye Drops in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Dry Eye Therapy Eye Drops in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Dry Eye Therapy Eye Drops Industry Trends Table 2. Dry Eye Therapy Eye Drops Industry Drivers Table 3. Dry Eye Therapy Eye Drops Industry Opportunities and Challenges Table 4. Dry Eye Therapy Eye Drops Industry Restraints Table 5. Global Dry Eye Therapy Eye Drops Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Dry Eye Therapy Eye Drops Revenue Share by Company (2021-2026) Table 7. Global Dry Eye Therapy Eye Drops Sales Volume by Company (K Units) & (2021-2026) Table 8. Global Dry Eye Therapy Eye Drops Sales Volume Share by Company (2021-2026) Table 9. Global Dry Eye Therapy Eye Drops Average Price (US$/Unit) of Company (2021-2026) Table 10. Global Dry Eye Therapy Eye Drops Company Ranking, (2024-2026) & (USD Million) Table 11. Global Dry Eye Therapy Eye Drops Key Company Manufacturing Base & Headquarters Table 12. Global Dry Eye Therapy Eye Drops Company, Product Type & Application Table 13. Global Dry Eye Therapy Eye Drops Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Dry Eye Therapy Eye Drops by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Sodium Hyaluronate Eye Drops Table 18. Significant Companies of Sodium Carboxymethylcellulose Eye Drops Table 19. Significant Companies of Other Table 20. Global Dry Eye Therapy Eye Drops Sales Volume by Type 2021 VS 2025 VS 2032 (K Units) Table 21. Global Dry Eye Therapy Eye Drops Sales Volume by Type (2021-2026) & (K Units) Table 22. Global Dry Eye Therapy Eye Drops Sales Volume by Type (2027-2032) & (K Units) Table 23. Global Dry Eye Therapy Eye Drops Sales Volume Share by Type (2021-2026) Table 24. Global Dry Eye Therapy Eye Drops Sales Volume Share by Type (2027-2032) Table 25. Global Dry Eye Therapy Eye Drops Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Dry Eye Therapy Eye Drops Sales Value by Type (2021-2026) & (US$ Million) Table 27. Global Dry Eye Therapy Eye Drops Sales Value by Type (2027-2032) & (US$ Million) Table 28. Global Dry Eye Therapy Eye Drops Sales Value Share by Type (2021-2026) Table 29. Global Dry Eye Therapy Eye Drops Sales Value Share by Type (2027-2032) Table 30. Significant Companies of Middle Age Table 31. Significant Companies of Teenagers Table 32. Significant Companies of Older Adult Table 33. Global Dry Eye Therapy Eye Drops Sales Volume by Application 2021 VS 2025 VS 2032 (K Units) Table 34. Global Dry Eye Therapy Eye Drops Sales Volume by Application (2021-2026) & (K Units) Table 35. Global Dry Eye Therapy Eye Drops Sales Volume by Application (2027-2032) & (K Units) Table 36. Global Dry Eye Therapy Eye Drops Sales Volume Share by Application (2021-2026) Table 37. Global Dry Eye Therapy Eye Drops Sales Volume Share by Application (2027-2032) Table 38. Global Dry Eye Therapy Eye Drops Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 39. Global Dry Eye Therapy Eye Drops Sales Value by Application (2021-2026) & (US$ Million) Table 40. Global Dry Eye Therapy Eye Drops Sales Value by Application (2027-2032) & (US$ Million) Table 41. Global Dry Eye Therapy Eye Drops Sales Value Share by Application (2021-2026) Table 42. Global Dry Eye Therapy Eye Drops Sales Value Share by Application (2027-2032) Table 43. Global Dry Eye Therapy Eye Drops Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 44. Global Dry Eye Therapy Eye Drops Sales by Region (2021-2026) & (K Units) Table 45. Global Dry Eye Therapy Eye Drops Sales Market Share by Region (2021-2026) Table 46. Global Dry Eye Therapy Eye Drops Sales by Region (2027-2032) & (K Units) Table 47. Global Dry Eye Therapy Eye Drops Sales Market Share by Region (2027-2032) Table 48. Global Dry Eye Therapy Eye Drops Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 49. Global Dry Eye Therapy Eye Drops Sales Value by Region (2021-2026) & (US$ Million) Table 50. Global Dry Eye Therapy Eye Drops Sales Value Share by Region (2021-2026) Table 51. Global Dry Eye Therapy Eye Drops Sales Value by Region (2027-2032) & (US$ Million) Table 52. Global Dry Eye Therapy Eye Drops Sales Value Share by Region (2027-2032) Table 53. Global Dry Eye Therapy Eye Drops Market Average Price (US$/Unit) by Region (2021-2026) Table 54. Global Dry Eye Therapy Eye Drops Market Average Price (US$/Unit) by Region (2027-2032) Table 55. Global Dry Eye Therapy Eye Drops Sales by Country: 2021 VS 2025 VS 2032 (K Units) Table 56. Global Dry Eye Therapy Eye Drops Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 57. Global Dry Eye Therapy Eye Drops Sales by Country (2021-2026) & (K Units) Table 58. Global Dry Eye Therapy Eye Drops Sales Market Share by Country (2021-2026) Table 59. Global Dry Eye Therapy Eye Drops Sales by Country (2027-2032) & (K Units) Table 60. Global Dry Eye Therapy Eye Drops Sales Market Share by Country (2027-2032) Table 61. Global Dry Eye Therapy Eye Drops Sales Value by Country (2021-2026) & (US$ Million) Table 62. Global Dry Eye Therapy Eye Drops Sales Value Market Share by Country (2021-2026) Table 63. Global Dry Eye Therapy Eye Drops Sales Value by Country (2027-2032) & (US$ Million) Table 64. Global Dry Eye Therapy Eye Drops Sales Value Market Share by Country (2027-2032) Table 65. Novartis Company Information Table 66. Novartis Business Overview Table 67. Novartis Dry Eye Therapy Eye Drops Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 68. Novartis Dry Eye Therapy Eye Drops Product Portfolio Table 69. Novartis Recent Development Table 70. Rohto Company Information Table 71. Rohto Business Overview Table 72. Rohto Dry Eye Therapy Eye Drops Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 73. Rohto Dry Eye Therapy Eye Drops Product Portfolio Table 74. Rohto Recent Development Table 75. CooperVision Company Information Table 76. CooperVision Business Overview Table 77. CooperVision Dry Eye Therapy Eye Drops Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 78. CooperVision Dry Eye Therapy Eye Drops Product Portfolio Table 79. CooperVision Recent Development Table 80. Santen Pharma Company Information Table 81. Santen Pharma Business Overview Table 82. Santen Pharma Dry Eye Therapy Eye Drops Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 83. Santen Pharma Dry Eye Therapy Eye Drops Product Portfolio Table 84. Santen Pharma Recent Development Table 85. Alcon Company Information Table 86. Alcon Business Overview Table 87. Alcon Dry Eye Therapy Eye Drops Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 88. Alcon Dry Eye Therapy Eye Drops Product Portfolio Table 89. Alcon Recent Development Table 90. AbbVie Company Information Table 91. AbbVie Business Overview Table 92. AbbVie Dry Eye Therapy Eye Drops Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 93. AbbVie Dry Eye Therapy Eye Drops Product Portfolio Table 94. AbbVie Recent Development Table 95. Zhenshiming Company Information Table 96. Zhenshiming Business Overview Table 97. Zhenshiming Dry Eye Therapy Eye Drops Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 98. Zhenshiming Dry Eye Therapy Eye Drops Product Portfolio Table 99. Zhenshiming Recent Development Table 100. URSAPHARM Company Information Table 101. URSAPHARM Business Overview Table 102. URSAPHARM Dry Eye Therapy Eye Drops Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 103. URSAPHARM Dry Eye Therapy Eye Drops Product Portfolio Table 104. URSAPHARM Recent Development Table 105. Thea pharmaceuticals Company Information Table 106. Thea pharmaceuticals Business Overview Table 107. Thea pharmaceuticals Dry Eye Therapy Eye Drops Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 108. Thea pharmaceuticals Dry Eye Therapy Eye Drops Product Portfolio Table 109. Thea pharmaceuticals Recent Development Table 110. Prestige Consumer Healthcare Company Information Table 111. Prestige Consumer Healthcare Business Overview Table 112. Prestige Consumer Healthcare Dry Eye Therapy Eye Drops Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 113. Prestige Consumer Healthcare Dry Eye Therapy Eye Drops Product Portfolio Table 114. Prestige Consumer Healthcare Recent Development Table 115. OmniVision Pharma Company Information Table 116. OmniVision Pharma Business Overview Table 117. OmniVision Pharma Dry Eye Therapy Eye Drops Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 118. OmniVision Pharma Dry Eye Therapy Eye Drops Product Portfolio Table 119. OmniVision Pharma Recent Development Table 120. LION Company Information Table 121. LION Business Overview Table 122. LION Dry Eye Therapy Eye Drops Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 123. LION Dry Eye Therapy Eye Drops Product Portfolio Table 124. LION Recent Development Table 125. Kenvue (VISINE) Company Information Table 126. Kenvue (VISINE) Business Overview Table 127. Kenvue (VISINE) Dry Eye Therapy Eye Drops Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 128. Kenvue (VISINE) Dry Eye Therapy Eye Drops Product Portfolio Table 129. Kenvue (VISINE) Recent Development Table 130. Bausch Health Company Information Table 131. Bausch Health Business Overview Table 132. Bausch Health Dry Eye Therapy Eye Drops Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 133. Bausch Health Dry Eye Therapy Eye Drops Product Portfolio Table 134. Bausch Health Recent Development Table 135. Key Raw Materials Table 136. Raw Materials Key Suppliers Table 137. Dry Eye Therapy Eye Drops Distributors List Table 138. Dry Eye Therapy Eye Drops Customers List Table 139. Research Programs/Design for This Report Table 140. Authors List of This Report Table 141. Secondary Sources Table 142. Primary Sources List of Figures Figure 1. Dry Eye Therapy Eye Drops Product Image Figure 2. Global Dry Eye Therapy Eye Drops Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Dry Eye Therapy Eye Drops Sales Value (2021-2032) & (US$ Million) Figure 4. Global Dry Eye Therapy Eye Drops Sales (2021-2032) & (K Units) Figure 5. Global Dry Eye Therapy Eye Drops Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global Dry Eye Therapy Eye Drops Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Sodium Hyaluronate Eye Drops Image Figure 10. Sodium Carboxymethylcellulose Eye Drops Image Figure 11. Other Image Figure 12. Global Dry Eye Therapy Eye Drops Sales Volume by Type (2021 VS 2025 VS 2032) & (K Units) Figure 13. Global Dry Eye Therapy Eye Drops Sales Volume Share 2021 VS 2025 VS 2032 Figure 14. Global Dry Eye Therapy Eye Drops Sales Volume Share by Type (2021-2032) Figure 15. Global Dry Eye Therapy Eye Drops Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Dry Eye Therapy Eye Drops Sales Value Share 2021 VS 2025 VS 2032 Figure 17. Global Dry Eye Therapy Eye Drops Sales Value Share by Type (2021-2032) Figure 18. Middle Age Image Figure 19. Teenagers Image Figure 20. Older Adult Image Figure 21. Global Dry Eye Therapy Eye Drops Sales Volume by Application (2021 VS 2025 VS 2032) & (K Units) Figure 22. Global Dry Eye Therapy Eye Drops Sales Volume Share 2021 VS 2025 VS 2032 Figure 23. Global Dry Eye Therapy Eye Drops Sales Volume Share by Application (2021-2032) Figure 24. Global Dry Eye Therapy Eye Drops Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 25. Global Dry Eye Therapy Eye Drops Sales Value Share 2021 VS 2025 VS 2032 Figure 26. Global Dry Eye Therapy Eye Drops Sales Value Share by Application (2021-2032) Figure 27. Global Dry Eye Therapy Eye Drops Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 28. Global Dry Eye Therapy Eye Drops Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 29. Global Dry Eye Therapy Eye Drops Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 30. Global Dry Eye Therapy Eye Drops Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 31. North America Dry Eye Therapy Eye Drops Sales Value (2021-2032) & (US$ Million) Figure 32. North America Dry Eye Therapy Eye Drops Sales Value Share by Country (%), 2025 VS 2032 Figure 33. Europe Dry Eye Therapy Eye Drops Sales Value (2021-2032) & (US$ Million) Figure 34. Europe Dry Eye Therapy Eye Drops Sales Value Share by Country (%), 2025 VS 2032 Figure 35. Asia-Pacific Dry Eye Therapy Eye Drops Sales Value (2021-2032) & (US$ Million) Figure 36. Asia-Pacific Dry Eye Therapy Eye Drops Sales Value Share by Country (%), 2025 VS 2032 Figure 37. South America Dry Eye Therapy Eye Drops Sales Value (2021-2032) & (US$ Million) Figure 38. South America Dry Eye Therapy Eye Drops Sales Value Share by Country (%), 2025 VS 2032 Figure 39. Middle East & Africa Dry Eye Therapy Eye Drops Sales Value (2021-2032) & (US$ Million) Figure 40. Middle East & Africa Dry Eye Therapy Eye Drops Sales Value Share by Country (%), 2025 VS 2032 Figure 41. USA Dry Eye Therapy Eye Drops Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. USA Dry Eye Therapy Eye Drops Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. USA Dry Eye Therapy Eye Drops Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. Canada Dry Eye Therapy Eye Drops Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. Canada Dry Eye Therapy Eye Drops Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. Canada Dry Eye Therapy Eye Drops Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. Mexico Dry Eye Therapy Eye Drops Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. Mexico Dry Eye Therapy Eye Drops Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. Mexico Dry Eye Therapy Eye Drops Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Germany Dry Eye Therapy Eye Drops Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Germany Dry Eye Therapy Eye Drops Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Germany Dry Eye Therapy Eye Drops Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. France Dry Eye Therapy Eye Drops Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. France Dry Eye Therapy Eye Drops Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. France Dry Eye Therapy Eye Drops Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. U.K. Dry Eye Therapy Eye Drops Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. U.K. Dry Eye Therapy Eye Drops Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. U.K. Dry Eye Therapy Eye Drops Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Italy Dry Eye Therapy Eye Drops Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Italy Dry Eye Therapy Eye Drops Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Italy Dry Eye Therapy Eye Drops Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Spain Dry Eye Therapy Eye Drops Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Spain Dry Eye Therapy Eye Drops Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Spain Dry Eye Therapy Eye Drops Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. Russia Dry Eye Therapy Eye Drops Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. Russia Dry Eye Therapy Eye Drops Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. Russia Dry Eye Therapy Eye Drops Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Netherlands Dry Eye Therapy Eye Drops Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Netherlands Dry Eye Therapy Eye Drops Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Netherlands Dry Eye Therapy Eye Drops Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. Nordic Countries Dry Eye Therapy Eye Drops Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. Nordic Countries Dry Eye Therapy Eye Drops Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. Nordic Countries Dry Eye Therapy Eye Drops Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. China Dry Eye Therapy Eye Drops Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. China Dry Eye Therapy Eye Drops Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. China Dry Eye Therapy Eye Drops Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Japan Dry Eye Therapy Eye Drops Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Japan Dry Eye Therapy Eye Drops Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Japan Dry Eye Therapy Eye Drops Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. South Korea Dry Eye Therapy Eye Drops Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. South Korea Dry Eye Therapy Eye Drops Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. South Korea Dry Eye Therapy Eye Drops Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. India Dry Eye Therapy Eye Drops Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. India Dry Eye Therapy Eye Drops Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. India Dry Eye Therapy Eye Drops Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Australia Dry Eye Therapy Eye Drops Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Australia Dry Eye Therapy Eye Drops Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Australia Dry Eye Therapy Eye Drops Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Southeast Asia Dry Eye Therapy Eye Drops Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Southeast Asia Dry Eye Therapy Eye Drops Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Southeast Asia Dry Eye Therapy Eye Drops Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Brazil Dry Eye Therapy Eye Drops Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Brazil Dry Eye Therapy Eye Drops Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Brazil Dry Eye Therapy Eye Drops Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Argentina Dry Eye Therapy Eye Drops Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Argentina Dry Eye Therapy Eye Drops Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Argentina Dry Eye Therapy Eye Drops Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Chile Dry Eye Therapy Eye Drops Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Chile Dry Eye Therapy Eye Drops Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Chile Dry Eye Therapy Eye Drops Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Colombia Dry Eye Therapy Eye Drops Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Colombia Dry Eye Therapy Eye Drops Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Colombia Dry Eye Therapy Eye Drops Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. Peru Dry Eye Therapy Eye Drops Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. Peru Dry Eye Therapy Eye Drops Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. Peru Dry Eye Therapy Eye Drops Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Saudi Arabia Dry Eye Therapy Eye Drops Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Saudi Arabia Dry Eye Therapy Eye Drops Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Saudi Arabia Dry Eye Therapy Eye Drops Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Israel Dry Eye Therapy Eye Drops Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Israel Arabia Dry Eye Therapy Eye Drops Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Israel Arabia Dry Eye Therapy Eye Drops Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. UAE Dry Eye Therapy Eye Drops Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. UAE Dry Eye Therapy Eye Drops Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. UAE Dry Eye Therapy Eye Drops Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. Turkey Dry Eye Therapy Eye Drops Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 117. Turkey Dry Eye Therapy Eye Drops Sales Value Share by Type, 2025 VS 2032 & (%) Figure 118. Turkey Dry Eye Therapy Eye Drops Sales Value Share by Application, 2025 VS 2032 & (%) Figure 119. Iran Dry Eye Therapy Eye Drops Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 120. Iran Dry Eye Therapy Eye Drops Sales Value Share by Type, 2025 VS 2032 & (%) Figure 121. Iran Dry Eye Therapy Eye Drops Sales Value Share by Application, 2025 VS 2032 & (%) Figure 122. Egypt Dry Eye Therapy Eye Drops Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 123. Egypt Dry Eye Therapy Eye Drops Sales Value Share by Type, 2025 VS 2032 & (%) Figure 124. Egypt Dry Eye Therapy Eye Drops Sales Value Share by Application, 2025 VS 2032 & (%) Figure 125. Dry Eye Therapy Eye Drops Value Chain Figure 126. Manufacturing Cost Structure Figure 127. Dry Eye Therapy Eye Drops Sales Mode & Process Figure 128. Direct Comparison with Distribution Share Figure 129. Distributors Profiles Figure 130. Years Considered Figure 131. Research Process Figure 132. Key Executives Interviewed

Scope & coverage.

Types
  • Sodium Hyaluronate Eye Drops
  • Sodium Carboxymethylcellulose Eye Drops
  • Other
Applications
  • Middle Age
  • Teenagers
  • Older Adult
Companies covered
  • Novartis
  • Rohto
  • CooperVision
  • Santen Pharma
  • Alcon
  • AbbVie
  • Zhenshiming
  • URSAPHARM
  • Thea pharmaceuticals
  • Prestige Consumer Healthcare
  • OmniVision Pharma
  • LION
  • Kenvue (VISINE)
  • Bausch Health

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Dry Eye Therapy Eye Drops Sales Value (2021-2032)
  4. 1.2.2 Global Dry Eye Therapy Eye Drops Sales Volume (2021-2032)
  5. 1.2.3 Global Dry Eye Therapy Eye Drops Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Dry Eye Therapy Eye Drops Market Dynamics
  1. 2.1 Dry Eye Therapy Eye Drops Industry Trends
  2. 2.2 Dry Eye Therapy Eye Drops Industry Drivers
  3. 2.3 Dry Eye Therapy Eye Drops Industry Opportunities and Challenges
  4. 2.4 Dry Eye Therapy Eye Drops Industry Restraints
3 Dry Eye Therapy Eye Drops Market by Company
  1. 3.1 Global Dry Eye Therapy Eye Drops Company Revenue Ranking in 2025
  2. 3.2 Global Dry Eye Therapy Eye Drops Revenue by Company (2021-2026)
  3. 3.3 Global Dry Eye Therapy Eye Drops Sales Volume by Company (2021-2026)
  4. 3.4 Global Dry Eye Therapy Eye Drops Average Price by Company (2021-2026)
  5. 3.5 Global Dry Eye Therapy Eye Drops Company Ranking (2024-2026)
  6. 3.6 Global Dry Eye Therapy Eye Drops Company Manufacturing Base and Headquarters
  7. 3.7 Global Dry Eye Therapy Eye Drops Company Product Type and Application
  8. 3.8 Global Dry Eye Therapy Eye Drops Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Dry Eye Therapy Eye Drops Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Dry Eye Therapy Eye Drops Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Dry Eye Therapy Eye Drops Market by Type
  1. 4.1 Dry Eye Therapy Eye Drops Type Introduction
  2. 4.1.1 Sodium Hyaluronate Eye Drops
  3. 4.1.2 Sodium Carboxymethylcellulose Eye Drops
  4. 4.1.3 Other
  5. 4.2 Global Dry Eye Therapy Eye Drops Sales Volume by Type
  6. 4.2.1 Global Dry Eye Therapy Eye Drops Sales Volume by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Dry Eye Therapy Eye Drops Sales Volume by Type (2021-2032)
  8. 4.2.3 Global Dry Eye Therapy Eye Drops Sales Volume Share by Type (2021-2032)
  9. 4.3 Global Dry Eye Therapy Eye Drops Sales Value by Type
  10. 4.3.1 Global Dry Eye Therapy Eye Drops Sales Value by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Dry Eye Therapy Eye Drops Sales Value by Type (2021-2032)
  12. 4.3.3 Global Dry Eye Therapy Eye Drops Sales Value Share by Type (2021-2032)
5 Dry Eye Therapy Eye Drops Market by Application
  1. 5.1 Dry Eye Therapy Eye Drops Application Introduction
  2. 5.1.1 Middle Age
  3. 5.1.2 Teenagers
  4. 5.1.3 Older Adult
  5. 5.2 Global Dry Eye Therapy Eye Drops Sales Volume by Application
  6. 5.2.1 Global Dry Eye Therapy Eye Drops Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Dry Eye Therapy Eye Drops Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Dry Eye Therapy Eye Drops Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Dry Eye Therapy Eye Drops Sales Value by Application
  10. 5.3.1 Global Dry Eye Therapy Eye Drops Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Dry Eye Therapy Eye Drops Sales Value by Application (2021-2032)
  12. 5.3.3 Global Dry Eye Therapy Eye Drops Sales Value Share by Application (2021-2032)
6 Dry Eye Therapy Eye Drops Regional Sales and Value Analysis
  1. 6.1 Global Dry Eye Therapy Eye Drops Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Dry Eye Therapy Eye Drops Sales by Region (2021-2032)
  3. 6.2.1 Global Dry Eye Therapy Eye Drops Sales by Region: 2021-2026
  4. 6.2.2 Global Dry Eye Therapy Eye Drops Sales by Region (2027-2032)
  5. 6.3 Global Dry Eye Therapy Eye Drops Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Dry Eye Therapy Eye Drops Sales Value by Region (2021-2032)
  7. 6.4.1 Global Dry Eye Therapy Eye Drops Sales Value by Region: 2021-2026
  8. 6.4.2 Global Dry Eye Therapy Eye Drops Sales Value by Region (2027-2032)
  9. 6.5 Global Dry Eye Therapy Eye Drops Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Dry Eye Therapy Eye Drops Sales Value (2021-2032)
  12. 6.6.2 North America Dry Eye Therapy Eye Drops Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Dry Eye Therapy Eye Drops Sales Value (2021-2032)
  15. 6.7.2 Europe Dry Eye Therapy Eye Drops Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Dry Eye Therapy Eye Drops Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Dry Eye Therapy Eye Drops Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Dry Eye Therapy Eye Drops Sales Value (2021-2032)
  21. 6.9.2 South America Dry Eye Therapy Eye Drops Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Dry Eye Therapy Eye Drops Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Dry Eye Therapy Eye Drops Sales Value Share by Country, 2025 VS 2032
7 Dry Eye Therapy Eye Drops Country-level Sales and Value Analysis
  1. 7.1 Global Dry Eye Therapy Eye Drops Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Dry Eye Therapy Eye Drops Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Dry Eye Therapy Eye Drops Sales by Country (2021-2032)
  4. 7.3.1 Global Dry Eye Therapy Eye Drops Sales by Country (2021-2026)
  5. 7.3.2 Global Dry Eye Therapy Eye Drops Sales by Country (2027-2032)
  6. 7.4 Global Dry Eye Therapy Eye Drops Sales Value by Country (2021-2032)
  7. 7.4.1 Global Dry Eye Therapy Eye Drops Sales Value by Country (2021-2026)
  8. 7.4.2 Global Dry Eye Therapy Eye Drops Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Dry Eye Therapy Eye Drops Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Dry Eye Therapy Eye Drops Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Dry Eye Therapy Eye Drops Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Dry Eye Therapy Eye Drops Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Dry Eye Therapy Eye Drops Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Dry Eye Therapy Eye Drops Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Dry Eye Therapy Eye Drops Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Dry Eye Therapy Eye Drops Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Dry Eye Therapy Eye Drops Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Dry Eye Therapy Eye Drops Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Dry Eye Therapy Eye Drops Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Dry Eye Therapy Eye Drops Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Dry Eye Therapy Eye Drops Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Dry Eye Therapy Eye Drops Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Dry Eye Therapy Eye Drops Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Dry Eye Therapy Eye Drops Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Dry Eye Therapy Eye Drops Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Dry Eye Therapy Eye Drops Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Dry Eye Therapy Eye Drops Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Dry Eye Therapy Eye Drops Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Dry Eye Therapy Eye Drops Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Dry Eye Therapy Eye Drops Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Dry Eye Therapy Eye Drops Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Dry Eye Therapy Eye Drops Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Dry Eye Therapy Eye Drops Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Dry Eye Therapy Eye Drops Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Dry Eye Therapy Eye Drops Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Dry Eye Therapy Eye Drops Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Dry Eye Therapy Eye Drops Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Dry Eye Therapy Eye Drops Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Dry Eye Therapy Eye Drops Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Dry Eye Therapy Eye Drops Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Dry Eye Therapy Eye Drops Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Dry Eye Therapy Eye Drops Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Dry Eye Therapy Eye Drops Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Dry Eye Therapy Eye Drops Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Dry Eye Therapy Eye Drops Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Dry Eye Therapy Eye Drops Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Dry Eye Therapy Eye Drops Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Dry Eye Therapy Eye Drops Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Dry Eye Therapy Eye Drops Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Dry Eye Therapy Eye Drops Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Dry Eye Therapy Eye Drops Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Dry Eye Therapy Eye Drops Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Dry Eye Therapy Eye Drops Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Dry Eye Therapy Eye Drops Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Dry Eye Therapy Eye Drops Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Dry Eye Therapy Eye Drops Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Dry Eye Therapy Eye Drops Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Dry Eye Therapy Eye Drops Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Dry Eye Therapy Eye Drops Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Dry Eye Therapy Eye Drops Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Dry Eye Therapy Eye Drops Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Dry Eye Therapy Eye Drops Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Dry Eye Therapy Eye Drops Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Dry Eye Therapy Eye Drops Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Dry Eye Therapy Eye Drops Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Dry Eye Therapy Eye Drops Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Dry Eye Therapy Eye Drops Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Dry Eye Therapy Eye Drops Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Dry Eye Therapy Eye Drops Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Dry Eye Therapy Eye Drops Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Dry Eye Therapy Eye Drops Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Dry Eye Therapy Eye Drops Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Dry Eye Therapy Eye Drops Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Dry Eye Therapy Eye Drops Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Dry Eye Therapy Eye Drops Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Dry Eye Therapy Eye Drops Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Dry Eye Therapy Eye Drops Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Dry Eye Therapy Eye Drops Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Dry Eye Therapy Eye Drops Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Dry Eye Therapy Eye Drops Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Dry Eye Therapy Eye Drops Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Dry Eye Therapy Eye Drops Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Dry Eye Therapy Eye Drops Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Dry Eye Therapy Eye Drops Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Dry Eye Therapy Eye Drops Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Dry Eye Therapy Eye Drops Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Dry Eye Therapy Eye Drops Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Dry Eye Therapy Eye Drops Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Dry Eye Therapy Eye Drops Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Dry Eye Therapy Eye Drops Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Dry Eye Therapy Eye Drops Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Dry Eye Therapy Eye Drops Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Novartis
  2. 8.1.1 Novartis Company Information
  3. 8.1.2 Novartis Business Overview
  4. 8.1.3 Novartis Dry Eye Therapy Eye Drops Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Novartis Dry Eye Therapy Eye Drops Product Portfolio
  6. 8.1.5 Novartis Recent Developments
  7. 8.2 Rohto
  8. 8.2.1 Rohto Company Information
  9. 8.2.2 Rohto Business Overview
  10. 8.2.3 Rohto Dry Eye Therapy Eye Drops Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Rohto Dry Eye Therapy Eye Drops Product Portfolio
  12. 8.2.5 Rohto Recent Developments
  13. 8.3 CooperVision
  14. 8.3.1 CooperVision Company Information
  15. 8.3.2 CooperVision Business Overview
  16. 8.3.3 CooperVision Dry Eye Therapy Eye Drops Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 CooperVision Dry Eye Therapy Eye Drops Product Portfolio
  18. 8.3.5 CooperVision Recent Developments
  19. 8.4 Santen Pharma
  20. 8.4.1 Santen Pharma Company Information
  21. 8.4.2 Santen Pharma Business Overview
  22. 8.4.3 Santen Pharma Dry Eye Therapy Eye Drops Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Santen Pharma Dry Eye Therapy Eye Drops Product Portfolio
  24. 8.4.5 Santen Pharma Recent Developments
  25. 8.5 Alcon
  26. 8.5.1 Alcon Company Information
  27. 8.5.2 Alcon Business Overview
  28. 8.5.3 Alcon Dry Eye Therapy Eye Drops Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Alcon Dry Eye Therapy Eye Drops Product Portfolio
  30. 8.5.5 Alcon Recent Developments
  31. 8.6 AbbVie
  32. 8.6.1 AbbVie Company Information
  33. 8.6.2 AbbVie Business Overview
  34. 8.6.3 AbbVie Dry Eye Therapy Eye Drops Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 AbbVie Dry Eye Therapy Eye Drops Product Portfolio
  36. 8.6.5 AbbVie Recent Developments
  37. 8.7 Zhenshiming
  38. 8.7.1 Zhenshiming Company Information
  39. 8.7.2 Zhenshiming Business Overview
  40. 8.7.3 Zhenshiming Dry Eye Therapy Eye Drops Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Zhenshiming Dry Eye Therapy Eye Drops Product Portfolio
  42. 8.7.5 Zhenshiming Recent Developments
  43. 8.8 URSAPHARM
  44. 8.8.1 URSAPHARM Company Information
  45. 8.8.2 URSAPHARM Business Overview
  46. 8.8.3 URSAPHARM Dry Eye Therapy Eye Drops Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 URSAPHARM Dry Eye Therapy Eye Drops Product Portfolio
  48. 8.8.5 URSAPHARM Recent Developments
  49. 8.9 Thea pharmaceuticals
  50. 8.9.1 Thea pharmaceuticals Company Information
  51. 8.9.2 Thea pharmaceuticals Business Overview
  52. 8.9.3 Thea pharmaceuticals Dry Eye Therapy Eye Drops Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Thea pharmaceuticals Dry Eye Therapy Eye Drops Product Portfolio
  54. 8.9.5 Thea pharmaceuticals Recent Developments
  55. 8.10 Prestige Consumer Healthcare
  56. 8.10.1 Prestige Consumer Healthcare Company Information
  57. 8.10.2 Prestige Consumer Healthcare Business Overview
  58. 8.10.3 Prestige Consumer Healthcare Dry Eye Therapy Eye Drops Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Prestige Consumer Healthcare Dry Eye Therapy Eye Drops Product Portfolio
  60. 8.10.5 Prestige Consumer Healthcare Recent Developments
  61. 8.11 OmniVision Pharma
  62. 8.11.1 OmniVision Pharma Company Information
  63. 8.11.2 OmniVision Pharma Business Overview
  64. 8.11.3 OmniVision Pharma Dry Eye Therapy Eye Drops Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 OmniVision Pharma Dry Eye Therapy Eye Drops Product Portfolio
  66. 8.11.5 OmniVision Pharma Recent Developments
  67. 8.12 LION
  68. 8.12.1 LION Company Information
  69. 8.12.2 LION Business Overview
  70. 8.12.3 LION Dry Eye Therapy Eye Drops Sales, Value and Gross Margin (2021-2026)
  71. 8.12.4 LION Dry Eye Therapy Eye Drops Product Portfolio
  72. 8.12.5 LION Recent Developments
  73. 8.13 Kenvue (VISINE)
  74. 8.13.1 Kenvue (VISINE) Company Information
  75. 8.13.2 Kenvue (VISINE) Business Overview
  76. 8.13.3 Kenvue (VISINE) Dry Eye Therapy Eye Drops Sales, Value and Gross Margin (2021-2026)
  77. 8.13.4 Kenvue (VISINE) Dry Eye Therapy Eye Drops Product Portfolio
  78. 8.13.5 Kenvue (VISINE) Recent Developments
  79. 8.14 Bausch Health
  80. 8.14.1 Bausch Health Company Information
  81. 8.14.2 Bausch Health Business Overview
  82. 8.14.3 Bausch Health Dry Eye Therapy Eye Drops Sales, Value and Gross Margin (2021-2026)
  83. 8.14.4 Bausch Health Dry Eye Therapy Eye Drops Product Portfolio
  84. 8.14.5 Bausch Health Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Dry Eye Therapy Eye Drops Value Chain Analysis
  2. 9.1.1 Dry Eye Therapy Eye Drops Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Dry Eye Therapy Eye Drops Sales Mode & Process
  6. 9.2 Dry Eye Therapy Eye Drops Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Dry Eye Therapy Eye Drops Distributors
  9. 9.2.3 Dry Eye Therapy Eye Drops Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst